Get the Stockscreener App
2.8512
1.04%
-0.0388
Sunshine Biopharma Inc stock is traded at $2.8512, with a volume of 39,367.
It is down -1.04% in the last 24 hours and down -9.78% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
See More
Previous Close:
$2.89
Open:
$2.93
24h Volume:
39,367
Relative Volume:
0.24
Market Cap:
$5.78M
Revenue:
$24.09M
Net Income/Loss:
$-4.51M
P/E Ratio:
-1.6971
EPS:
-1.68
Net Cash Flow:
$-9.56M
1W Performance:
-1.04%
1M Performance:
-9.78%
6M Performance:
-82.98%
1Y Performance:
-99.51%
1-Day Range:
$2.81
$2.93
1-Week Range:
$2.77
$3.00
52-Week Range:
$2.42
$640.00
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-515-0810
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Sunshine Biopharma Inc Stock (SBFM) Latest News
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat
Sunshine Biopharma announces Nora Pharma launch of two new generic drugs - TipRanks
Sunshine Biopharma expands generic drug portfolio - Investing.com
Sunshine Biopharma’s Nora Pharma launches two generic prescription drugs - TipRanks
Sunshine Biopharma Launches Two New Generic Prescription Drugs - AccessWire
A new trading data show Sunshine Biopharma Inc (SBFM) is showing positive returns. - SETE News
Sunshine Biopharma Inc (SBFM) Stock: Navigating a Year of Volatility - The InvestChronicle
How is SBFM’s stock performing after recent trades? - US Post News
Sunshine Biopharma meets Nasdaq compliance requirements By Investing.com - Investing.com Australia
Sunshine Biopharma meets Nasdaq compliance requirements - Investing.com
Sunshine Biopharma announces publication of coronavirus research results - TipRanks
Sunshine Biopharma reports potential SARS-CoV-2 treatment By Investing.com - Investing.com Canada
Sunshine Biopharma reports potential SARS-CoV-2 treatment - Investing.com
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Lelezard
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth - GlobeNewswire
Is Sunshine Biopharma, Inc. (SBFM) The Best Rated Penny Stock To Buy According to Analysts? - MSN
10 Best Rated Penny Stocks To Buy According to Analysts - Insider Monkey
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada - AccessWire
Sunshine Biopharma’s Revenues and Profits Surge - TipRanks
SBFM (Sunshine Biopharma) Operating Income : $-4.31 Mil (TTM As of Mar. 2024) - GuruFocus.com
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% - AccessWire
Sunshine Biopharma (NASDAQ:SBFM) Issues Quarterly Earnings Results - Defense World
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 9.6% - MarketBeat
SBFM (Sunshine Biopharma) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Cyclically Adjusted PS Ratio : 0.00 (As of Aug. 16, 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Financial Strength : 7 (As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Long-Term Debt & Capital Lease Ob - GuruFocus.com
Sunshine Biopharma enacts 1-for-20 reverse stock split By Investing.com - Investing.com Australia
Sunshine Biopharma enacts 1-for-20 reverse stock split - Investing.com
Sunshine Biopharma stock hits 52-week low at $0.15 - Investing.com
SBFM’s Stock Performance: A Year of Mixed Fortunes & Market Shifts - The InvestChronicle
How does Sunshine Biopharma Inc (SBFM) change from a tortoise to a hare? - SETE News
Technical analysis of Sunshine Biopharma Inc (SBFM) stock chart patterns - US Post News
Sunshine Biopharma Announces Reverse Stock Split - StockTitan
It makes sense and dollars to buy Sunshine Biopharma Inc (SBFM) stock - SETE News
Anchoring Your Portfolio: Is SBFM Stock a Safe Harbor? - The InvestChronicle
A stock that deserves closer examination: Sunshine Biopharma Inc (SBFM) - US Post News
Ratio Examination: Sunshine Biopharma Inc (SBFM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Are Smart Investors Making the Right Decision? Sunshine Biopharma Inc (SBFM) - SETE News
Stock Surge: Sunshine Biopharma Inc (SBFM) Closes at 0.30, Marking a -5.82 Increase/Decrease - The Dwinnex
Sunshine Biopharma Inc (SBFM) is looking forward to a strong quarter - SETE News
It would be worthwhile to take a closer look at Sunshine Biopharma Inc (SBFM) - US Post News
There is no doubt that Sunshine Biopharma Inc (SBFM) ticks all the boxes. - SETE News
Can you still get a good price for Sunshine Biopharma Inc (SBFM) Shares at this point? - US Post News
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):